We are your partner in utilizing the potential of molecular tumor profiling
NEO New Oncology is your partner for implementing modern technology for molecular tumor analysis in research, development and diagnostics.
Technology: We offer you an innovative solution portfolio that is adapted to laboratory routine procedures. The NEO technology thus supports you in the expansion of molecular tumor analysis for precision oncology or clinical research. Our assays provide comprehensive information on tumor biology for the best possible oncological therapy recommendation and for meaningful research results.
Competence: NEOs expertise lies in the development and continuous optimization of assays solutions for molecular cancer diagnostics and clinical research. Our team works closely with key experts in various business fields of Siemens Healthineers, research laboratories and the pharmaceutical industry to leverage molecular tumor profiling for improving precision medicine.
Service: To ensure efficient utilization of hybrid capture technology in research, development and diagnostics, you are supported by an experienced team. Our team is available on short notice to support all steps of the application of our technology.
Since May 2016, NEO New Oncology has been a subsidiary of Siemens Healthineers.
Do you want to learn more about our technology for molecular tumor analysis? Please contact us!